A Systematic Review of Cervical Cancer Mobile Applications and a Future Directions for Developers
- PMID: 39471008
- PMCID: PMC11711358
- DOI: 10.31557/APJCP.2024.25.10.3429
A Systematic Review of Cervical Cancer Mobile Applications and a Future Directions for Developers
Abstract
Objective: The objective of this study is to evaluate the quality of mobile health (mHealth) applications that promote cervical cancer awareness and provide screening assistance, with an emphasis on apps available on the Google Play Store and iOS.
Methods: From December 2023 to February 2024, we assessed mobile applications focused on cervical cancer screening that are available on Google Play and Apple iTunes. The "Cervical Cancer," "Mobile Application," "Pap Test," "Cervical Cancer Guide," "Human Papillomavirus," plus "Cervical Screening are the keywords used to search the applications." Data collection includes features such as application name, pricing, download metrics, invention date, last update, affiliation, online access, login requirements, and notification functionality, which were gathered in Excel. Interrater reliability based on four reviewers' independent judgments, varied from 0.75 to 0.83.
Result: In our research, we found 25 apps (16 on the Google Play Store and 9 on iOS). After a thorough review, only 14 relevant apps were included. According to the MARS rating, Rise Against Cancer received the highest score (3.9), followed by FightHPV and Cervical Cancer Forum (3.8). Rise Against Cancer (29), HPV Vaccine (28), and CDC STI Tx Guidelines (28) scored highest in the APPLICATIONS rating system. Hope 4 All and OCI Cervibreast closely matched the statements, meeting seven of the thirteen requirements each.
Conclusion: Future app developers should produce user-friendly, often updated mHealth applications that include high-quality cervical cancer awareness and screening content. These apps should provide validated information and pleasant graphic effects.
Keywords: APPLICATIONS scoring; Cervical cancer; Mobile Rating Scale; Screening.
Conflict of interest statement
Authors declare that there is no conflict of interest.
Figures
Similar articles
-
Mobile health applications for epilepsy in Indian app stores: A systematic review and content analysis using the mobile app rating scale.Epilepsy Res. 2024 Mar;201:107331. doi: 10.1016/j.eplepsyres.2024.107331. Epub 2024 Feb 22. Epilepsy Res. 2024. PMID: 38442549
-
Quality Assessment of Smartphone Medication Management Apps in France: Systematic Search.JMIR Mhealth Uhealth. 2024 Mar 18;12:e54866. doi: 10.2196/54866. JMIR Mhealth Uhealth. 2024. PMID: 38498042 Free PMC article.
-
Monitoring Symptoms of COVID-19: Review of Mobile Apps.JMIR Mhealth Uhealth. 2022 Jun 1;10(6):e36065. doi: 10.2196/36065. JMIR Mhealth Uhealth. 2022. PMID: 35609313 Free PMC article.
-
Evaluation of mobile health applications for cervical cancer in the digital marketplace.Obstet Gynecol Sci. 2022 May;65(3):244-255. doi: 10.5468/ogs.22037. Epub 2022 Apr 5. Obstet Gynecol Sci. 2022. PMID: 35381627 Free PMC article.
-
Popular Evidence-Based Commercial Mental Health Apps: Analysis of Engagement, Functionality, Aesthetics, and Information Quality.JMIR Mhealth Uhealth. 2021 Jul 14;9(7):e29689. doi: 10.2196/29689. JMIR Mhealth Uhealth. 2021. PMID: 34259639 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous